Abstract:Background: Dual antiplatelet therapy reduces the risk of thrombotic complications after primary percutaneous coronary intervention (PCI). Aim: To assess whether inhibition of platelet function attenuates microvascular damage in patients with ST-segment elevation myocardial infarction (STEMI). Methods: We studied 83 STEMI patients treated with primary PCI. Platelet aggregation was measured on admission (ADM) and 4 days later (D4) by light transmission aggregometry after stimulation with 0.5 mM of arachidonic acid and after stimulation with 5 and 20 μM of adenosine diphosphate (ADP) on treatment with dual antiplatelet therapy with aspirin and clopidogrel. Platelet-neutrophil aggregate (PNA) and platelet-monocyte aggregate (PMA) were analysed by flow cytometry. Contrast-enhanced magnetic resonance imaging was performed 2-4 days after STEMI to detect the area of perfusion defect at rest and to determine the size of microvascular obstruction. Microvascular obstruction was expressed as a percentage of infarct area. Results: Perfusion defect at rest was found in 56 (67.5%) patients whereas microvascular obstruction in 63 (75.9%) patients. Patients with perfusion defect at rest had on admission a significantly higher level of both PMA (7.0 vs. 4.5%, p = 0.004) and PNA (4.1 vs. 2.2%, p = 0.016), however there were no significant differences at D4. Platelet aggregation after stimulation with 5 μM of ADP on ADM was correlated (r = 0.37, p = 0.004) with microvascular obstruction area. Moreover, the higher the concentration of PMA(ADM) (r = 0.31, p = 0.016), PNA(ADM) (r = 0.34, p = 0.006) and PM(AD4) (r = 0.35, p = 0.005) the larger the size of microvascular obstruction. Infarct size (β = 0.43, 95% CI 0.19 to 0.67, p 〈 0.0001), TIMI < 3 after PCI (β = -0.27, 95% CI -1.90 to -0.11, p = 0.015) and PMA(D4) (β = 0.21, 95% CI 0.13 to 1.86, p = 0.032) independently influenced the size of microvascular obstruction (R2 = 0.60, p 〈 0.0001). Conclusions: Excessive platelet activation during reperfusion in STEMI patients despite dual antiplatelet therapy is associated with greater microvascular impairment.

Changes of Platelet Activation Markers and Platelet Ultra-Microstructure in the Patients with Acute Myocardial Infarction

Identification Of Potential Biomarkers And Immune Cell Infiltration In Acute Myocardial Infarction (Ami) Using Bioinformatics Strategy

The Research about the State of the Activated Blood Platelet of Cerebral Infarction Patients

Change of Platelet Activity and Vascular Endothelium Function in Patients with Acute Coronary Syndrome After Treatment by Percutaneous Coronary Intervention

Change of Serum Level of Platelet Activity and Inflammation Factors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention and Their Clinical Significance

Study on expression of platelet membrane glycoproteins in cerebral infarction with carotid atherosclerosis

Changes In Microparticles In Intracoronary Thrombi And Peripheral Arterial Blood In Patients With St-Segment Elevation Myocardial Infarction

Study on Platelet Activation and Platelet Parameters in Patients with Cerebral Infarction

Platelet Ultrastructural and Functional Studies in Patients with Acute Cerebral Infarction

The Dynamic Changes of Platelet P-selectin and Glycoprotein V in Acute Myocardial Infarction

Changes of Plasma P-selectin、 Thrombomodulin、 Plasminogen Activator Inhibitor-1 of Coronary Artery Disease Patients Before and after PTCA

Changes of Reticulated Platelets and Platelet Parameters in Acute Coronary Syndrome and Their Significance

Changes of Plasma Macrophage Migration Inhibitory Factor Level in Patients with Acute Myocardial Infarction and Its Clinical Significance

Changes of the platelet Golgi apparatus in patients with acute cerebral infarction

[Dynamic Changes of Plasma VEGF, SDF-1 and Peripheral CD34+ Cells in Patients with Acute Myocardial Infarction].

The Role of Platelet Parameters in the Clinical Assessment of Acute Myocardial Infarction

Dynamic changes of neotrophil and platelet counts in patients undergoing primary percutaneous coronary intervention

Platelet activation and microvascular injury in patients with ST-segment elevation myocardial infarction

Effect of percutaneous coronary intervention on inflammatory reactions and platelet activation in patients with acute coronary syndrome

Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation

Expression of Inflammatory and Apoptosis Factors Following Coronary Stent Implantation in Coronary Heart Disease Patients